Antivirulence Strategies for the Treatment of Staphylococcus aureus Infections: A Mini Review

Staphylococcus aureus is a Gram-positive bacterium capable of infecting nearly all host tissues, causing severe morbidity and mortality. Widespread antimicrobial resistance has emerged among S. aureus clinical isolates, which are now the most frequent causes of nosocomial infection among drug-resist...

Full description

Bibliographic Details
Main Authors: Caleb A. Ford, Ian M. Hurford, James E. Cassat
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2020.632706/full
_version_ 1811271037257515008
author Caleb A. Ford
Ian M. Hurford
James E. Cassat
James E. Cassat
James E. Cassat
James E. Cassat
James E. Cassat
author_facet Caleb A. Ford
Ian M. Hurford
James E. Cassat
James E. Cassat
James E. Cassat
James E. Cassat
James E. Cassat
author_sort Caleb A. Ford
collection DOAJ
description Staphylococcus aureus is a Gram-positive bacterium capable of infecting nearly all host tissues, causing severe morbidity and mortality. Widespread antimicrobial resistance has emerged among S. aureus clinical isolates, which are now the most frequent causes of nosocomial infection among drug-resistant pathogens. S. aureus produces an array of virulence factors that enhance in vivo fitness by liberating nutrients from the host or evading host immune responses. Staphylococcal virulence factors have been identified as viable therapeutic targets for treatment, as they contribute to disease pathogenesis, tissue injury, and treatment failure. Antivirulence strategies, or treatments targeting virulence without direct toxicity to the inciting pathogen, show promise as an adjunctive therapy to traditional antimicrobials. This Mini Review examines recent research on S. aureus antivirulence strategies, with an emphasis on translational studies. While many different virulence factors have been investigated as therapeutic targets, this review focuses on strategies targeting three virulence categories: pore-forming toxins, immune evasion mechanisms, and the S. aureus quorum sensing system. These major areas of S. aureus antivirulence research demonstrate broad principles that may apply to other human pathogens. Finally, challenges of antivirulence research are outlined including the potential for resistance, the need to investigate multiple infection models, and the importance of studying antivirulence in conjunction with traditional antimicrobial treatments.
first_indexed 2024-04-12T22:13:04Z
format Article
id doaj.art-6fad2bb01f8c48189926761fc6ad3435
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-04-12T22:13:04Z
publishDate 2021-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-6fad2bb01f8c48189926761fc6ad34352022-12-22T03:14:39ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2021-01-011110.3389/fmicb.2020.632706632706Antivirulence Strategies for the Treatment of Staphylococcus aureus Infections: A Mini ReviewCaleb A. Ford0Ian M. Hurford1James E. Cassat2James E. Cassat3James E. Cassat4James E. Cassat5James E. Cassat6Department of Biomedical Engineering, Vanderbilt University, Nashville, TN, United StatesDepartment of Pediatrics, Division of Pediatric Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, United StatesDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN, United StatesDepartment of Pediatrics, Division of Pediatric Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, United StatesDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, United StatesVanderbilt Center for Bone Biology, Vanderbilt University Medical Center, Nashville, TN, United StatesVanderbilt Institute for Infection, Immunology, and Inflammation (VI4), Vanderbilt University Medical Center, Nashville, TN, United StatesStaphylococcus aureus is a Gram-positive bacterium capable of infecting nearly all host tissues, causing severe morbidity and mortality. Widespread antimicrobial resistance has emerged among S. aureus clinical isolates, which are now the most frequent causes of nosocomial infection among drug-resistant pathogens. S. aureus produces an array of virulence factors that enhance in vivo fitness by liberating nutrients from the host or evading host immune responses. Staphylococcal virulence factors have been identified as viable therapeutic targets for treatment, as they contribute to disease pathogenesis, tissue injury, and treatment failure. Antivirulence strategies, or treatments targeting virulence without direct toxicity to the inciting pathogen, show promise as an adjunctive therapy to traditional antimicrobials. This Mini Review examines recent research on S. aureus antivirulence strategies, with an emphasis on translational studies. While many different virulence factors have been investigated as therapeutic targets, this review focuses on strategies targeting three virulence categories: pore-forming toxins, immune evasion mechanisms, and the S. aureus quorum sensing system. These major areas of S. aureus antivirulence research demonstrate broad principles that may apply to other human pathogens. Finally, challenges of antivirulence research are outlined including the potential for resistance, the need to investigate multiple infection models, and the importance of studying antivirulence in conjunction with traditional antimicrobial treatments.https://www.frontiersin.org/articles/10.3389/fmicb.2020.632706/fullStaphylococcus aureus – bacteriaantivirulenceantimicrobial resistancevirulenceinfectionquorum sensing
spellingShingle Caleb A. Ford
Ian M. Hurford
James E. Cassat
James E. Cassat
James E. Cassat
James E. Cassat
James E. Cassat
Antivirulence Strategies for the Treatment of Staphylococcus aureus Infections: A Mini Review
Frontiers in Microbiology
Staphylococcus aureus – bacteria
antivirulence
antimicrobial resistance
virulence
infection
quorum sensing
title Antivirulence Strategies for the Treatment of Staphylococcus aureus Infections: A Mini Review
title_full Antivirulence Strategies for the Treatment of Staphylococcus aureus Infections: A Mini Review
title_fullStr Antivirulence Strategies for the Treatment of Staphylococcus aureus Infections: A Mini Review
title_full_unstemmed Antivirulence Strategies for the Treatment of Staphylococcus aureus Infections: A Mini Review
title_short Antivirulence Strategies for the Treatment of Staphylococcus aureus Infections: A Mini Review
title_sort antivirulence strategies for the treatment of staphylococcus aureus infections a mini review
topic Staphylococcus aureus – bacteria
antivirulence
antimicrobial resistance
virulence
infection
quorum sensing
url https://www.frontiersin.org/articles/10.3389/fmicb.2020.632706/full
work_keys_str_mv AT calebaford antivirulencestrategiesforthetreatmentofstaphylococcusaureusinfectionsaminireview
AT ianmhurford antivirulencestrategiesforthetreatmentofstaphylococcusaureusinfectionsaminireview
AT jamesecassat antivirulencestrategiesforthetreatmentofstaphylococcusaureusinfectionsaminireview
AT jamesecassat antivirulencestrategiesforthetreatmentofstaphylococcusaureusinfectionsaminireview
AT jamesecassat antivirulencestrategiesforthetreatmentofstaphylococcusaureusinfectionsaminireview
AT jamesecassat antivirulencestrategiesforthetreatmentofstaphylococcusaureusinfectionsaminireview
AT jamesecassat antivirulencestrategiesforthetreatmentofstaphylococcusaureusinfectionsaminireview